Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:25 pm Sale | 2024-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Alyeska Investment Group L.P. | 75,628 2.500% | -180,780 (-70.50%) | Filing History |
| 2025-02-12 11:39 am Sale | 2024-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | GOLDMAN SACHS GROUP INC GS | 130 0.000% | -180,662 (-99.93%) | Filing History |
| 2025-02-10 4:03 pm Purchase | 2024-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors Inc. | 715,231 9.900% | 250,554 (+53.92%) | Filing History |
| 2025-02-10 08:38 am Purchase | 2024-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | HIRSCHMAN ORIN | 255,555 8.500% | 255,555 (New Position) | Filing History |
| 2024-11-14 7:17 pm Purchase | 2024-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 109,160 3.500% | 109,160 (New Position) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Nantahala Capital Management LLC | 306,262 9.990% | 306,262 (New Position) | Filing History |
| 2024-11-14 4:45 pm Purchase | 2024-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | ADAR1 Capital Management LLC | 315,103 9.990% | 315,103 (New Position) | Filing History |
| 2024-11-14 4:32 pm Purchase | 2024-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Alyeska Investment Group L.P. | 256,408 8.400% | 256,408 (New Position) | Filing History |
| 2024-11-13 5:34 pm Purchase | 2024-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Stonepine Capital Management LLC | 307,229 9.990% | 307,229 (New Position) | Filing History |
| 2024-11-12 5:58 pm Purchase | 2024-09-30 | 13G | Kiora Pharmaceuticals, Inc. KPRX | GOLDMAN SACHS GROUP INC GS | 180,792 6.100% | 180,792 (New Position) | Filing History |
| 2024-05-29 3:47 pm Unchanged | 2024-03-28 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors Inc. | 464,677 9.900% | 0 (Unchanged) | Filing History |
| 2024-05-29 3:43 pm Purchase | 2024-03-28 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Rosalind Advisors Inc. | 464,677 9.900% | 464,677 (New Position) | Filing History |
| 2024-02-14 4:55 pm Purchase | 2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lincoln Park Capital Fund LLC | 260,731 9.990% | 251,618 (+2761.26%) | Filing History |
| 2024-02-13 8:08 pm Purchase | 2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 93,889 9.900% | 55,499 (+144.57%) | Filing History |
| 2024-02-09 4:16 pm Purchase | 2024-01-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Stonepine Capital Management LLC | 267,673 9.990% | 267,673 (New Position) | Filing History |
| 2024-02-07 09:22 am Purchase | 2024-02-01 | 13G | Kiora Pharmaceuticals, Inc. KPRX | HIRSCHMAN ORIN | 255,556 9.900% | 255,556 (New Position) | Filing History |
| 2024-02-06 10:27 am Sale | 2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Mitchell P. Kopin | 13,012 1.500% | -6,185 (-32.22%) | Filing History |
| 2023-06-13 4:02 pm Purchase | 2023-06-06 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 38,390 9.900% | 21,382 (+125.72%) | Filing History |
| 2023-02-14 1:01 pm Purchase | 2022-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | ARMISTICE CAPITAL LLC | 10,000 4.770% | 10,000 (New Position) | Filing History |
| 2023-02-13 4:38 pm Purchase | 2022-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Lind Global Fund II LP | 17,008 7.900% | 17,008 (New Position) | Filing History |